Learn about how FluidAI Medical’s postoperative monitoring solution is leveraging AI to detect anastomotic leaks and improve recovery times.
Medtech company DiagnaMed leverages the SOPHIE program to accelerate commercialization timelines of CERVAI™, their novel brain health AI platform.
Femtech startup Cosm Medical is changing women’s pelvic health with a medical device that combines software, AI and 3D printing.
With support from the Government of Canada, Innovation Factory launches the Canadian Medtech Alliance (CAMEDA) program.
Innovation Factory announces an MOU with HaloHealth to deliver a collaborative medical assessment & physician advisory service to SOPHIE companies.
Discover how the SOPHIE program guided Epineuron Technologies’ efforts towards a pain-free future for people with peripheral nerve damage.
Through the SOPHIE program, PreOperative Performance will enter a 12-month co-development partnership with The Research
Allarta Life Science leverages the SOPHIE program with the goal of licensing technology and commercializing treatments.
Explore the impact of life science innovation in Hamilton’s economy, driving growth through the SOPHIE program and new technologies.
Making a smart site selection could drive the commercialization of your intellectual property. Here are three examples that are helping to make Hamilton, Ontario, the next leader in life sciences research and commercialization.
Eye3 has gained significant traction including securing financing, developing product concepts and prototypes and filing for patents.
Understanding the common commercialization hurdles mentioned above is one thing, but having the funding and the time to navigate through them is another.
Esphera SynBio, a synthetic biology platform is reprogramming the human body’s own communication system to deliver new cancer and infectious disease therapeutics, a solution with the power to impact many lives.
Kapoose Creek Bio is working with McMaster University for drug discovery and development to innovate treatments for neurological conditions.
Discover how Stoked Bio is leveraging resources like the SOPHIE program to advance AI-driven drug discovery.
Esphera SynBio, a synthetic biology platform is reprogramming the human body’s own communication system to deliver new cancer and infectious disease therapeutics, a solution with the power to impact many lives.
Kapoose Creek Bio is working with McMaster University for drug discovery and development to innovate treatments for neurological conditions.
Discover how Stoked Bio is leveraging resources like the SOPHIE program to advance AI-driven drug discovery.
Minister Tassi announces $5M Government of Canada investment into SOPHIE program renewal to support Canadian life sciences innovation.
Since 2021, Innovation Factory’s SOPHIE program has helped support the growth of over 160 innovative Ontario life science companies.
The Molecules and Masterpieces event showcased the SOPHIE program’s role as a catalyst for life science partnerships, commercialization and innovation.
Our website uses cookies to ensure you get the best experience. Learn more about the policy.
